Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

ARCA biopharma (ABIO) Short Interest Ratio & Short Volume

ARCA biopharma logo

ARCA biopharma Short Interest Data

ARCA biopharma (ABIO) has a short interest of 4.99 million shares, representing 37.10% of the float (the number of shares available for trading by the public). This marks a 13.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 50.3, indicating that it would take 50.3 days of the average trading volume of 607,995 shares to cover all short positions.

Current Short Interest
4,990,000 shares
Previous Short Interest
4,400,000 shares
Change Vs. Previous Month
+13.41%
Dollar Volume Sold Short
$14.32 million
Short Interest Ratio
50.3 Days to Cover
Last Record Date
August 15, 2024
Outstanding Shares
14,507,000 shares
Float Size
13,450,000 shares
Short Percent of Float
37.10%
Today's Trading Volume
290,800 shares
Average Trading Volume
607,995 shares
Today's Volume Vs. Average
48%
Short Selling ARCA biopharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ARCA biopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ABIO Short Interest Over Time

ABIO Days to Cover Over Time

ABIO Percentage of Float Shorted Over Time

ARCA biopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/15/20244,990,000 shares $14.32 million +13.4%37.1%50.3 $2.87
7/31/20244,400,000 shares $13.20 million +4.0%32.4%49.8 $3.00
7/15/20244,230,000 shares $14.72 million +1.2%31.2%38 $3.48
6/30/20244,180,000 shares $16.01 million +1.0%30.8%30.9 $3.83
6/15/20244,140,000 shares $13.70 million No Change30.5%2.9 $3.31
5/31/20244,140,000 shares $15.32 million +1.0%30.5%2.9 $3.70
5/15/20244,100,000 shares $15.25 million No Change30.2%2.9 $3.72
4/30/20244,100,000 shares $14.31 million -27.6%30.2%2.9 $3.49
4/15/20245,660,000 shares $18.00 million +2,792.2%39.6%4.1 $3.18
3/31/2024195,700 shares $344,432.00 +6.6%1.4%0.1 $1.76
3/15/2024183,600 shares $310,284.00 +0.7%1.3%6.3 $1.69
2/29/2024182,300 shares $297,149.00 -1.9%1.3%6.9 $1.63
2/15/2024185,900 shares $306,735.00 -1.2%1.3%7.2 $1.65
1/31/2024188,100 shares $299,079.00 -3.3%1.3%7.5 $1.59
1/15/2024194,600 shares $317,198.00 -0.4%1.4%7.7 $1.63
12/31/2023195,400 shares $332,180.00 -7.9%1.4%8 $1.70
12/15/2023212,200 shares $371,350.00 +3.9%1.5%9.1 $1.75
11/30/2023204,300 shares $371,826.00 -4.7%1.4%9.5 $1.82
11/15/2023214,400 shares $375,200.00 -2.6%1.5%9.4 $1.75
10/31/2023220,100 shares $391,778.00 -9.8%1.6%9.6 $1.78
10/15/2023243,900 shares $496,336.50 +3.8%1.7%11.6 $2.04
9/30/2023234,900 shares $472,149.00 -11.4%1.7%11.9 $2.01
9/15/2023265,000 shares $543,250.00 +9.5%1.9%12.9 $2.05
8/31/2023242,000 shares $496,100.00 -7.0%1.7%10.5 $2.05
8/15/2023260,300 shares $531,012.00 +2.4%1.8%10.6 $2.04
7/31/2023254,300 shares $518,772.00 -4.0%1.8%10.2 $2.04
7/15/2023264,800 shares $534,896.00 -2.9%1.9%9.9 $2.02
6/30/2023272,700 shares $553,581.00 -1.2%1.9%10.6 $2.03
6/15/2023276,100 shares $579,810.00 +1.3%1.9%10 $2.10
5/31/2023272,600 shares $575,186.00 +0.6%1.9%10.6 $2.11
5/15/2023270,900 shares $560,763.00 +1.6%1.9%11.1 $2.07
4/30/2023266,600 shares $533,200.00 +8.7%1.9%11.1 $2.00
4/15/2023245,200 shares $490,890.40 -12.6%1.7%10.2 $2.00
3/31/2023280,400 shares $557,996.00 +23.9%2.0%9.7 $1.99
3/15/2023226,300 shares $491,071.00 -7.1%1.6%5.8 $2.17
2/28/2023243,500 shares $535,700.00 -2.2%1.7%6.3 $2.20
2/15/2023248,900 shares $522,690.00 -3.8%1.8%6.6 $2.10
1/31/2023258,600 shares $568,920.00 -9.0%1.8%6.7 $2.20
1/15/2023284,300 shares $666,683.50 -51.1%2.0%7.4 $2.35
12/30/2022581,500 shares $1.38 million +1,022.6%4.1%16.9 $2.37
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

12/15/202251,800 shares $120,176.00 -3.2%0.4%1.8 $2.32
11/30/202253,500 shares $111,815.00 +5.9%0.4%2 $2.09
11/15/202250,500 shares $101,000.00 -0.8%0.4%1.7 $2.00
10/31/202250,900 shares $109,435.00 -8.6%0.4%1.7 $2.15
10/15/202255,700 shares $114,185.00 -4.5%0.4%1.7 $2.05
9/30/202258,300 shares $120,098.00 -26.9%0.4%1.7 $2.06
9/15/202279,700 shares $186,498.00 +47.6%0.6%2 $2.34
8/31/202254,000 shares $126,360.00 -4.1%0.4%1.4 $2.34
8/15/202256,300 shares $137,935.00 -2.3%0.4%1.4 $2.45
7/31/202257,600 shares $141,120.00 -19.3%0.4%1.1 $2.45
7/15/202271,400 shares $177,786.00 -32.4%0.5%1.2 $2.49
6/30/2022105,600 shares $262,944.00 -26.1%0.7%1.4 $2.49
6/15/2022142,800 shares $324,156.00 -14.9%1.0%1.1 $2.27
5/31/2022167,700 shares $400,803.00 -17.4%1.2%1.1 $2.39
5/15/2022202,900 shares $468,699.00 -7.7%1.4%1.3 $2.31
4/30/2022219,900 shares $521,163.00 -4.6%1.5%1.4 $2.37
4/15/2022230,500 shares $539,370.00 -18.8%1.6%1.4 $2.34
3/31/2022283,700 shares $652,510.00 +21.4%2.0%1.7 $2.30
3/15/2022233,700 shares $504,792.00 -15.7%1.6%1.5 $2.16
2/28/2022277,100 shares $562,513.00 -8.0%1.9%1.7 $2.03
2/15/2022301,100 shares $566,068.00 -6.3%2.1%1.5 $1.88
1/31/2022321,200 shares $607,068.00 -1.2%2.3%1.4 $1.89
1/15/2022325,200 shares $656,904.00 +2.6%2.3%0.7 $2.02
12/31/2021316,900 shares $681,335.00 -13.9%2.2%0.7 $2.15
12/15/2021368,200 shares $850,542.00 -26.3%2.6%0.8 $2.31
11/30/2021499,700 shares $1.18 million +10.9%3.5%1.2 $2.37
11/15/2021450,700 shares $1.10 million +54.1%3.1%1.3 $2.44
10/29/2021292,500 shares $801,450.00 -1.6%2.0%0.9 $2.74
10/15/2021297,200 shares $829,188.00 -6.4%2.1%1.3 $2.79
9/30/2021317,600 shares $940,096.00 -18.3%2.2%1.2 $2.96
9/15/2021388,900 shares $1.17 million -3.6%2.7%1.4 $3.02
8/31/2021403,200 shares $1.25 million -1.5%2.8%1.4 $3.09
8/13/2021409,200 shares $1.19 million -8.7%2.9%1.3 $2.92
7/30/2021448,300 shares $1.42 million +16.3%3.1%1.3 $3.16
7/15/2021385,500 shares $1.15 million +14.2%2.7%1.6 $2.99
6/30/2021337,600 shares $1.18 million +41.2%2.4%1.3 $3.49
6/15/2021239,100 shares $899,016.00 -26.1%1.7%0.9 $3.76
5/28/2021323,400 shares $1.13 million -31.6%2.3%0.9 $3.49
5/14/2021472,700 shares $1.45 million +24.8%N/A0.8 $3.07
4/30/2021378,900 shares $1.33 million -31.9%N/A0.4 $3.50
4/15/2021556,700 shares $1.93 million +18.2%N/A0.6 $3.46
3/31/2021471,200 shares $1.66 million +45.1%N/A0.5 $3.52
3/15/2021324,700 shares $1.39 million +64.3%N/A0.3 $4.27
2/26/2021197,600 shares $867,464.00 +65.1%N/A0.2 $4.39
2/12/2021119,700 shares $634,410.00 +293.8%N/A0.1 $5.30
1/29/202130,400 shares $127,072.00 -62.6%N/A0.1 $4.18
1/15/202181,200 shares $363,776.00 -35.9%N/A0.2 $4.48
12/31/2020126,700 shares $516,936.00 +208.3%N/A0.3 $4.08
12/15/202041,100 shares $176,730.00 -17.5%N/A0.1 $4.30
11/30/202049,800 shares $213,144.00 +18.6%N/A0.1 $4.28
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

11/15/202042,000 shares $169,260.00 -18.3%N/A0.1 $4.03
10/30/202051,400 shares $198,918.00 -40.4%N/A0.1 $3.87
10/15/202086,300 shares $359,008.00 -40.8%N/A0.1 $4.16
9/30/2020145,800 shares $644,436.00 +169.0%N/A0.1 $4.42
9/15/202054,200 shares $283,466.00 -19.7%N/A0.1 $5.23
8/31/202067,500 shares $308,475.00 -23.2%N/A0.1 $4.57
8/14/202087,900 shares $523,005.00 +112.3%N/A0 $5.95
7/31/202041,400 shares $289,800.00 +88.2%N/A0 $7.00
7/15/202022,000 shares $142,120.00 -13.4%N/A0 $6.46
6/30/202025,400 shares $170,180.00 +63.9%N/A0 $6.70
6/15/202015,500 shares $110,515.00 +82.4%N/A0 $7.13
5/29/20208,500 shares $163,285.00 -62.7%N/A0 $19.21
5/15/202022,800 shares $88,008.00 -14.9%N/A1 $3.86
4/30/202026,800 shares $98,088.00 -18.3%N/A0.9 $3.66
4/15/202032,800 shares $145,632.00 -33.1%N/A1.1 $4.44
3/31/202049,000 shares $195,020.00 +23.7%N/A1.4 $3.98
3/13/202039,600 shares $118,800.00 +1,484.0%N/A1.7 $3.00
2/28/20202,500 shares $6,350.00 -59.0%N/A0.1 $2.54
2/14/20206,100 shares $20,191.00 +60.5%N/A0.1 $3.31
1/31/20203,800 shares $15,694.00 -13.6%N/A0.1 $4.13
1/15/20204,400 shares $23,540.00 -21.4%N/A0.1 $5.35
12/31/20195,600 shares $31,472.00 -36.4%N/A0.1 $5.62

ABIO Short Interest - Frequently Asked Questions

What is ARCA biopharma's current short interest?

Short interest is the volume of ARCA biopharma shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 4,990,000 shares of ABIO short. 37.10% of ARCA biopharma's shares are currently sold short. Learn More on ARCA biopharma's current short interest.

What is a good short interest ratio for ARCA biopharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABIO shares currently have a short interest ratio of 50.0. Learn More on ARCA biopharma's short interest ratio.

What is a good short interest percentage for ARCA biopharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 37.10% of ARCA biopharma's floating shares are currently sold short.

Is ARCA biopharma's short interest increasing or decreasing?

ARCA biopharma saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 4,990,000 shares, an increase of 13.4% from the previous total of 4,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ARCA biopharma's float size?

ARCA biopharma currently has issued a total of 14,507,000 shares. Some of ARCA biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ARCA biopharma currently has a public float of 13,450,000 shares.

How does ARCA biopharma's short interest compare to its competitors?

37.10% of ARCA biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ARCA biopharma: ImmuCell Co. (0.09%), Vaxart, Inc. (6.35%), Adagene Inc. (0.03%), Telomir Pharmaceuticals, Inc. (3.22%), Rani Therapeutics Holdings, Inc. (7.18%), Nuvectis Pharma, Inc. (13.65%), INmune Bio, Inc. (15.70%), Journey Medical Co. (0.61%), Annovis Bio, Inc. (10.14%), PDS Biotechnology Co. (12.14%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short ARCA biopharma stock?

Short selling ABIO is an investing strategy that aims to generate trading profit from ARCA biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ARCA biopharma?

A short squeeze for ARCA biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABIO, which in turn drives the price of the stock up even further.

How often is ARCA biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABIO, twice per month. The most recent reporting period available is August, 15 2024.




This page (NASDAQ:ABIO) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners